LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tools for Meningitis Diagnostics Implemented in Resource-Limited Settings

By LabMedica International staff writers
Posted on 14 Jan 2019
Image: The Biofire FilmArray multiplex RT PCR system enables simultaneous testing for bacteria, viruses, yeast, parasites and/or antimicrobial resistant genes (Photo courtesy of bioMérieux).
Image: The Biofire FilmArray multiplex RT PCR system enables simultaneous testing for bacteria, viruses, yeast, parasites and/or antimicrobial resistant genes (Photo courtesy of bioMérieux).
Meningitis remains a top cause of premature death and loss of disability-adjusted life years in low-income countries. In resource-limited settings, proper laboratory diagnostics are often scarce and knowledge about national and local epidemiology is limited.

Misdiagnosis, incorrect treatment and overuse of antibiotics are potential consequences, especially for viral meningitis. Early treatment is essential in the clinical management of meningitis. A delay in therapy negatively affects the prognosis for patients with both bacterial and viral meningitis/encephalitis.

Scientists from the University of Oslo (Oslo, Norway) and their Ethiopian colleagues conducted a prospective study over three months in a teaching hospital in Ethiopia. Cerebrospinal fluid (CSF) samples were collected from patients with suspected meningitis. Basic routine testing with microscopy and culture were performed and clinical data, as well as information on treatment and outcome were collected.

CSF samples were cultured onto blood agar and/or chocolate agar for 72 hours at 35 °C in a CO2-enriched incubator (candle jar). Routine bacterial identification was based on colony morphology, Gram staining and standard biochemical reactions. All CSF samples included in the study were analyzed using the meningitis/encephalitis (ME) panel on the bioMérieux FilmArray multiplex polymerase chain reaction system (PCR) system. Two hundred and eighteen patients were included; 117 (54%) neonates (0–29 days), 63 (29%) pediatrics (1 month-15 years) and 38 (17%) adults (≥16 years).

The investigators reported that of 218 CSF samples, 21 (10%) were PCR positive; 4% in neonates, 14% in pediatrics and 18% in adults. Virus was detected in 57% of the PCR positive samples, bacteria in 33% and fungi in 10%. All CSF samples that were PCR positive for a bacterial agent had a white cell count ≥75 cells/mm3 and/or turbid appearance. Only four (2%) of the CSF samples included in the study were found to be positive for microorganisms using conventional methods (microscopy and/or culture).

The authors concluded that a rapid molecular diagnostic system was successfully implemented in an Ethiopian setting without previous experience of molecular diagnostics. Viral meningitis was diagnosed for the first time in routine clinical practice in Ethiopia, and viral agents were the most commonly detected microorganisms in CSF. This study illustrates the potential of rapid diagnostic tests for reducing antibiotic usage in suspected meningitis cases. The study was published on December 20, 2018, in the journal BMC Infectious Diseases.

Related Links:
University of Oslo

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more